Wells Fargo’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$96.7M Sell
313,865
-33,679
-10% -$10.4M 0.02% 674
2026
Q2
$97.3M Buy
347,544
+26,133
+8% +$6.87M 0.02% 699
2026
Q1
$85.8M Buy
321,411
+17,977
+6% +$4.87M 0.02% 696
2025
Q4
$76.1M Sell
303,434
-9,467
-3% -$2.51M 0.01% 727
2025
Q3
$89.8M Sell
312,901
-6,055
-2% -$1.62M 0.02% 631
2025
Q2
$83.7M Sell
318,956
-8,273
-3% -$2.01M 0.02% 643
2025
Q1
$76.2M Buy
327,229
+11,783
+4% +$2.86M 0.02% 635
2024
Q4
$72.3M Sell
315,446
-17,924
-5% -$4.11M 0.02% 649
2024
Q3
$74.5M Buy
333,370
+12,983
+4% +$2.85M 0.02% 640
2024
Q2
$65.2M Buy
320,387
+6,038
+2% +$1.23M 0.02% 661
2024
Q1
$68.7M Sell
314,349
-9,279
-3% -$2.04M 0.02% 639
2023
Q4
$73.6M Buy
323,628
+10,443
+3% +$2.19M 0.02% 579
2023
Q3
$63M Buy
313,185
+42,420
+16% +$8.95M 0.02% 590
2023
Q2
$65.3M Sell
270,765
-4,710
-2% -$1.06M 0.02% 598
2023
Q1
$63.2M Sell
275,475
-11,501
-4% -$2.75M 0.02% 606
2022
Q4
$67.6M Sell
286,976
-38,867
-12% -$8.84M 0.02% 565
2022
Q3
$66.7M Sell
325,843
-30,351
-9% -$7.23M 0.02% 534
2022
Q2
$83.5M Sell
356,194
-116,942
-25% -$29M 0.03% 478
2022
Q1
$125M Buy
473,136
+21,088
+5% +$5.77M 0.03% 425
2021
Q4
$142M Hold
452,048
– – 0.04% 377
2021
Q3
$160M Buy
568,343
+109,713
+24% +$32.2M 0.04% 472
2021
Q2
$127M Sell
458,630
-33,934
-7% -$9M 0.03% 564
2021
Q1
$126M Sell
492,564
-108,150
-18% -$25.3M 0.03% 557
2020
Q4
$122M Buy
600,714
+36,342
+6% +$7.31M 0.03% 546
2020
Q3
$106M Buy
564,372
+24,732
+5% +$4.56M 0.03% 540
2020
Q2
$89.6M Sell
539,640
-121,060
-18% -$19.5M 0.03% 587
2020
Q1
$83.5M Buy
660,700
+68,010
+11% +$11.4M 0.03% 534
2019
Q4
$100M Buy
592,690
+15,002
+3% +$2.52M 0.03% 574
2019
Q3
$97.1M Buy
577,688
+35,915
+7% +$6.1M 0.03% 579
2019
Q2
$93.7M Buy
541,773
+11,431
+2% +$1.86M 0.03% 604
2019
Q1
$81.1M Sell
530,342
-62,952
-11% -$9.03M 0.02% 642
2018
Q4
$75M Sell
593,294
-180,510
-23% -$28.1M 0.02% 630
2018
Q3
$134M Sell
773,804
-15,152
-2% -$2.68M 0.04% 476
2018
Q2
$142M Sell
788,956
-99,487
-11% -$17.5M 0.04% 447
2018
Q1
$144M Sell
888,443
-2,298
-0.3% -$393K 0.04% 441
2017
Q4
$142M Sell
890,741
-129,331
-13% -$19.9M 0.04% 444
2017
Q3
$154M Buy
1,020,072
+135,566
+15% +$21M 0.05% 405
2017
Q2
$136M Sell
884,506
-122,402
-12% -$17.4M 0.04% 435
2017
Q1
$144M Buy
1,006,908
+103,412
+11% +$14.3M 0.05% 405
2016
Q4
$116M Sell
903,496
-121,693
-12% -$15.7M 0.04% 454
2016
Q3
$141M Buy
1,025,189
+70,827
+7% +$9.7M 0.05% 395
2016
Q2
$124M Buy
954,362
+259,362
+37% +$32.5M 0.05% 410
2016
Q1
$81.4M Buy
695,000
+38,788
+6% +$4.33M 0.03% 535
2015
Q4
$81.1M Sell
656,212
-69,541
-10% -$8.35M 0.03% 533
2015
Q3
$78.7M Sell
725,753
-61,304
-8% -$7.38M 0.03% 551
2015
Q2
$95.4M Buy
787,057
+162,469
+26% +$19.7M 0.04% 515
2015
Q1
$78.8M Buy
624,588
+25,464
+4% +$3.05M 0.03% 587
2014
Q4
$64.6M Buy
599,124
+265,642
+80% +$27.3M 0.03% 635
2014
Q3
$33.9M Buy
333,482
+5,217
+2% +$549K 0.01% 945
2014
Q2
$33.6M Buy
328,265
+25,980
+9% +$2.62M 0.01% 973
2014
Q1
$29.7M Sell
302,285
-3,154
-1% -$293K 0.01% 1029
2013
Q4
$27.9M Sell
305,439
-64,293
-17% -$6.38M 0.01% 1056
2013
Q3
$36.7M Buy
369,732
+11,046
+3% +$1.08M 0.02% 849
2013
Q2
$35.9M Hold
358,686
– – 0.02% 807

Other funds holding LH

Wells Fargo's LH Position: Q3 2026 in Review

Wells Fargo reduced its Labcorp (LH) stake by 9.7% in Q3 2026, selling an estimated $10.4M and leaving 313,865 shares worth $96.7M. The position accounts for 0.02% of the portfolio, ranked #674.

Wells Fargo first reported a position in LH in Q2 2013 and has held it in 54 quarters since. The position peaked at $160M in Q3 2021. 1,095 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Wells Fargo held 313,865 shares of Labcorp worth $96.7M as of Q3 2026.
  • Wells Fargo sold 33,679 Labcorp shares in Q3 2026, an estimated $10.4M.
  • Labcorp made up 0.02% of Wells Fargo's portfolio in Q3 2026, its #674 holding.
  • Wells Fargo first reported a position in Labcorp in Q2 2013 and has held it in 54 quarters since.
  • Wells Fargo's Labcorp position peaked at $160M in Q3 2021.
  • 1,095 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.